Related by context. All words. (Click for frequent words.) 77 Elderly Patients 76 Study Evaluating 76 Patients Undergoing 76 Patients Treated 75 Statin Therapy 75 Pediatric Patients 75 Combination Treatment 75 Knee Osteoarthritis 75 Improves Survival 74 Improves Outcomes 74 Oral Fingolimod 74 Relapsing Multiple Sclerosis 74 FDA Approvals 74 Survival Benefit 74 Carotid Stenting 74 Venous Thromboembolism 74 Randomized Trials 74 Adjuvant Chemotherapy 74 Versus Placebo 74 Sirolimus Eluting Stent 74 Cardiovascular Events 74 Subgroup Analysis 74 Previously Treated 74 Pooled Analysis 74 Clinical Trial Results 73 Phase IIb Trial 73 Long Term Outcomes 73 Meets Primary Endpoint 73 Fracture Risk 73 Controlled Trial 73 Bare Metal Stents 73 Insulin Glargine 73 Total Knee Arthroplasty 73 Adjuvant Therapy 73 Stent Restenosis 73 Unfractionated Heparin 73 Metastatic Prostate Cancer 73 Clinical Outcome 73 Rheumatoid Arthritis Patients 73 Radiofrequency Ablation 73 Patients Suffering 72 Radical Prostatectomy 72 Postmenopausal Women 72 Treated Patients 72 Localized Prostate Cancer 72 Appears Safe 72 Heart Failure Patients 72 Ischemic Stroke 72 Completes Enrollment 72 Diabetic Patients 72 Neoadjuvant Chemotherapy 72 Hormone Receptor Positive 71 Previously Untreated 71 Advanced Prostate Cancer 71 Adjuvant Treatment 71 Antitumor Activity 71 Chronic Hepatitis C 71 Hypertensive Patients 71 Double Blind Placebo 71 Significantly Reduced 71 Chronic Hepatitis B 71 Randomized Controlled Trial 71 Liver Failure 71 Paclitaxel Eluting 71 II Clinical Trial 71 Acute Myocardial Infarction 71 Randomized Double Blind 71 Prostate Cancer Patients 71 Well Tolerated 71 Demonstrates Significant 71 Proves Effective 71 Inhaled Corticosteroids 71 Improved Survival 71 Shows Promising 71 Artery Disease 71 Phase 2a Clinical Trial 71 Catheter Ablation 71 Renal Cell Carcinoma 71 Phase 2b Clinical Trial 71 Prophylactic Treatment 71 Patients Treated With 71 Obese Patients 71 Acute Ischemic Stroke 70 Is Well Tolerated 70 Clinical Trial Evaluating 70 ORLive Presents 70 Bone Metastases 70 Phase III Clinical Trial 70 Statistically Significant 70 Myeloma Patients 70 Study Demonstrates 70 Robotic Assisted 70 Patency 70 Premature Infants 70 Estrogen Therapy 70 Controlled Study 70 Prolongs Survival 70 Breast Cancer Recurrence 70 Infarct 70 Randomized Clinical Trial 70 Patients Receiving 70 Overactive Bladder 70 Lung Cancers 70 Metastatic Renal Cell Carcinoma 70 Improve Survival 70 Osteoporosis Drugs 70 Hepatitis C Genotype 70 Monotherapy 70 Newly Diagnosed Multiple Myeloma 70 Stent Thrombosis 70 Study Showed 70 Phase 2b Trial 70 Platelet Inhibition 70 Dual Antiplatelet Therapy 70 Survival Rates 70 Phase III Trial 70 Randomized Controlled Trials 70 Lupus Drug 70 Lung Cancer Trial 70 Partial Onset Seizures 70 Cardiovascular Outcomes 70 HER2 Positive Breast Cancer 70 Autologous Stem Cell Transplantation 70 Pharmacokinetic Study 70 Demonstrates Positive 70 Osteoporosis Drug 70 Meta Analysis 70 Multicenter Trial 70 Lowers Risk 70 Predict Risk 70 Vertebral Compression Fractures 69 Bone Mineral Density 69 Patients Enrolled 69 Prospective Randomized 69 Fewer Side Effects 69 Orthostatic Hypotension 69 Breast Cancers 69 Placebo Controlled Trial 69 Single Dose 69 Increased Mortality 69 Migraine Headaches 69 Data Suggest 69 Long Term Efficacy 69 Fungal Infections 69 Severe Sepsis 69 Non Responders 69 Metastatic Colorectal Cancer 69 Long Term Survival 69 Surgical Treatment 69 Intracranial Aneurysms 69 Infarction 69 Advanced Melanoma 69 Drug Eluting 69 Randomized Study 69 Chemotherapy Regimen 69 Colorectal Cancers 69 Patient Enrollment 69 Relapsed Multiple Myeloma 69 Endovascular Treatment 69 Treatment Naïve 69 Hormone Therapy 69 Demonstrated Significant 69 Phase IIb Clinical Trial 69 Castration Resistant Prostate Cancer 69 Pivotal Phase 69 Shows Efficacy 69 Disease Progression 69 Critically Ill Patients 69 Proven Effective 69 Adjunctive Therapy 69 Less Invasive 69 Investigational Compound 69 Slow Progression 69 Hemodialysis Patients 69 Left Ventricular Hypertrophy 69 Investigational Agent 69 Phase IIa Clinical Trial 69 Left Ventricular 69 Increases Risk 69 Drug Candidate 69 Completes Patient Enrollment 69 Endometrial Cancer 69 Total Hip Replacement 69 Lung Cancer Survival 69 Advanced Ovarian Cancer 69 Diabetic Nephropathy 69 Colorectal Cancer Patients 69 Complicated Skin 69 Topline Results 69 Sirolimus Eluting 69 Drug Eluting Stents 68 Infected Patients 68 Significantly Reduces 68 Lung Cancer Patients 68 Antibiotic Treatment 68 Kidney Transplant Patients 68 Preterm Infants 68 Hormone Refractory Prostate Cancer 68 Non Invasive Treatment 68 Invasive Breast Cancer 68 Pulmonary Artery 68 Osteoporosis Treatment 68 Treatment Reduces 68 Hematological Cancers 68 Androgen Deprivation Therapy 68 Premenopausal Women 68 Unresectable 68 Cholesterol Lowering Drug 68 Non Inferiority 68 Randomized Phase 68 Migraine Pain 68 Gene Mutation 68 Preclinical Data 68 Stenting 68 Anti Tumor Activity 68 Chronic Sinusitis 68 Secondary Hyperparathyroidism 68 Migraine Drug 68 Randomized Placebo Controlled Trial 68 Relapsed Refractory 68 Drug Shows Promise 68 Symptom Relief 68 Uterine Fibroid Embolization 68 Chronic Myeloid Leukemia 68 Sustained Efficacy 68 Treating Chronic 68 LENALIDOMIDE 68 Panic Disorder 68 Breast Cancer Patients 68 Liver Tumors 68 Restenosis 68 Gene Variants 68 Blood Clots 68 Zoledronic Acid 68 Therapy Improves 68 Glycemic Control 68 Gout Drug 68 Bivalirudin 68 Depressive Symptoms 68 Emerging Therapies 68 JAK Inhibitor 68 J Clin 68 Recurrent Stroke 68 Novel Oral 68 Brain Metastases 68 Gum Disease 68 Anticancer Activity 68 Drug Combo 68 See CLINICAL PHARMACOLOGY 68 Cholesterol Levels 68 Venous Thrombosis 68 Neoadjuvant 67 IN PATIENTS WITH 67 Prostatectomy 67 Multiple Myeloma Patients 67 Plus Ribavirin 67 Pivotal Trial 67 IND Filing 67 Treatment Naive Patients 67 Periodontal Disease 67 ST Elevation Myocardial 67 Oral Cladribine 67 Clostridium difficile Infection 67 HER2 Positive 67 Phase III Trials 67 Acute Coronary Syndromes 67 Viral Suppression 67 Treatment Naive 67 Clinical Trial Data 67 Node Positive 67 Prostate Surgery 67 Blood Pressure Reduction 67 Lipid Levels 67 Eur J 67 Relapsing Remitting Multiple Sclerosis 67 Boosts Survival 67 Colorectal Adenomas 67 Chronic Bronchitis 67 Often Misdiagnosed 67 Mitral Regurgitation 67 Smoking Linked 67 Skin Lesions 67 Resistant Hypertension 67 Dose Escalation 67 Treatment Regimen 67 Endovascular Repair 67 Randomized Double Blind Placebo 67 Myocardial Infarction Study 67 Phase 2a Trial 67 Phase 2b Study 67 Multicenter Phase 67 Presents Positive 67 Chronic Heart Failure 67 Stent Placement 67 Pivotal Phase III 67 Gastric Cancer 67 ST Segment Elevation 67 Renal Impairment 67 Chronic Inflammation 67 Minimally Invasive Treatment 67 Investigational Drug 67 Newly Diagnosed Breast Cancer 67 Study Shows Significant 67 Significantly Improved 67 Phase Ib Clinical Trial 67 Peginterferon 67 Increased Risk 67 Clinical Outcomes 67 Sleep Disturbances 67 Drug Prevents 67 Cardiac Function 67 Coronary Stents 67 CT Angiography 67 Brain Atrophy 67 Drug Coated Stents 67 Desvenlafaxine Succinate 67 Acute Myocardial 67 Prognostic Significance 67 Cognitive Impairment 67 Kidney Transplant Recipients 67 Mouse Model 67 Prevent Stroke 67 Showed Significant 67 Prostate Cancer Treatment 67 Gene Linked 67 Physical Function 67 Newly Diagnosed 67 Partial Nephrectomy 67 Reduces Pain 67 Obesity Linked 67 Strongly Linked 67 Recurrent Prostate Cancer 67 Breast Cancer Treatment 67 Serious Infections 67 FDA Clears 67 Tolerability 67 Epilepsy Drug 67 Double Blind Randomized 67 Randomized Comparison 67 Combo Therapy 67 Patient Outcomes 67 Oral Anticoagulant 67 Diabetic Neuropathic Pain 67 Randomized Clinical Trials 66 Systematic Review 66 Kidney Function 66 Treating Depression 66 Pivotal Study 66 Antiviral Activity 66 Advanced Colorectal Cancer 66 Severe Asthma 66 Enoxaparin 66 Post Operative 66 Genes Associated 66 Survival Rate 66 Initiates Clinical Trials 66 First Patient Enrolled 66 Effective Than 66 Trial Evaluating 66 Potentially Fatal 66 Severe Acne 66 Effectively Treats 66 Cilostazol 66 Chronic Constipation 66 Cancer Diagnosis 66 Cognitive Function 66 Antidepressant Use 66 Low Dose 66 Beta Blocker 66 Cognitive Problems 66 Lowers Blood Pressure 66 Cognitive Decline 66 Reduces Mortality 66 Pivotal Clinical Trial 66 Menopausal Women 66 Phase III Pivotal Trial 66 Preclinical Study 66 Metastatic Melanoma 66 Genetic Mutations 66 Hip Fractures 66 Demonstrates Efficacy 66 Genes Predict 66 Complete Remission 66 Cholesterol Drugs 66 Tumor Growth 66 Reduce Mortality 66 Allergic Reactions 66 Peginterferon Alfa 2a 66 Treatment Experienced 66 CARDIOVASCULAR 66 Immunomedics Announces 66 Aggressive Prostate Cancer 66 Antipsychotic Drugs 66 Thrombotic 66 Chronic Cough 66 TRANSFORMS 66 Thromboembolism 66 Beta Blockers 66 Submits NDA 66 Stem Cell Treatment 66 Coronary Artery 66 Renal Tumors 66 Receives Orphan Drug Designation 66 Contrast Agent 66 Pre Cancerous 66 Treatment Resistant 66 Hepatocellular Carcinoma 66 Comorbidities 66 Beneficial Effects 66 Clinical Efficacy 66 NDA Submission 66 Topical Treatment 66 Systemic Sclerosis 66 Symptom Improvement 66 Improve Outcomes 66 Anti Clotting Drug 66 Surgical Procedures 66 Eluting Stent 66 J Am Acad 66 Aortic Valve Replacement 66 Carotid Endarterectomy 66 Initiates Clinical Trial 66 Kidney Transplants 66 Clinical Evaluation 66 Ranolazine 66 Multicenter Study 66 Higher Doses 66 Pregnancy Linked 66 Study Evaluates 66 Postmenopausal 66 Demonstrates Potent 66 Genes Linked 66 Surgery Performed 66 External Beam 66 Allergic Rhinitis 66 Poster Presentations 66 Chemotherapeutic Agents 66 Elevated Levels 66 TO AVOID PREGNANCY WHILE 66 Blocked Arteries 66 Gastric Bypass Surgery 66 Benign Prostatic Hyperplasia 66 Mylan Receives Approval 66 ACE Inhibitors 66 First Patient Dosed 66 HEART FAILURE 66 Nicotine Vaccine 66 Effective Treatments 66 Parathyroid Hormone 66 Iron Deficiency 66 Novel Method 66 Contrast Agents 66 FDA Approves Drug 66 Cell Transplants 66 Gene Variant 66 Significant Improvement 66 Genetic Disorder 66 Carboplatin Paclitaxel 66 Knee Arthritis 66 Renal Function 66 Placebo Controlled Study 66 Prognostic Value 66 Suicidality 66 Gene Variation 66 Genetic Variations 66 Pulmonary Arterial Hypertension 66 Observational Study 66 Cholesterol Drug 66 Significantly Improves 65 Randomized Evaluation 65 Predict Dementia 65 Chemoradiation 65 Statin Drugs 65 Radiation Doses 65 Placebo Controlled 65 Renal Artery 65 Cardiogenic Shock 65 HCV Protease Inhibitor 65 Antipsychotic Drug 65 Malignant Melanoma 65 Liver Metastases 65 Recurrent Ovarian Cancer 65 Myelodysplastic Syndromes 65 Blood Pressure Drug 65 FDA APPROVES 65 Investigational Treatment 65 Tiotropium 65 Intracerebral Hemorrhage 65 Endothelial Dysfunction 65 Liver Damage 65 Asthma Treatment 65 Orally Active 65 REMINDER ORLive Presents 65 Advanced Solid Tumors 65 Advanced Pancreatic Cancer 65 Gene Mutations 65 Chemotherapy Improves 65 Aortic Valve 65 Ovarian Cancer Patients 65 Prostate Cancer Recurrence 65 Erectile Dysfunction Drug 65 Inflammatory Markers 65 Slows Progression 65 MR Angiography 65 Hip Replacement Surgery 65 Demonstrates Sustained 65 Statistical Significance 65 Gastric Ulcers 65 Unstable Angina 65 Hepatitis C Treatment 65 Sinus Infections 65 Arthritis Drug 65 Dialysis Patients 65 Reduced Incidence 65 Lymphoma Patients 65 Vertebral Fractures 65 Bipolar Depression 65 Curr Opin 65 ER Visits 65 Adenoma 65 IND Application 65 Reduced Risk 65 Adverse Outcomes 65 Bone Grafting 65 Percutaneous Tibial Nerve Stimulation 65 Fixed Dose 65 Epoetin Alfa 65 Varicose Veins 65 Endothelial Function 65 Recur 65 Combination REOLYSIN R 65 Helps Predict 65 Potent Antiviral Activity 65 Safety Tolerability 65 Study Validates 65 Obese Teens 65 Cardiovascular Disease Risk 65 Anticancer Drugs 65 Randomised Trial 65 FDA Okays 65 Nebulized 65 Blood Pressure Lowering 65 Epileptic Seizures 65 J Shoulder Elbow 65 Sleep Duration 65 Enlarged Prostate 65 Plaque Psoriasis 65 Anticancer Drug 65 Neuroprotective Effects 65 Respiratory Distress 65 Therapy Shows Promise 65 Phospholipase A2 65 Brain Scans 65 Study Indicates 65 Being Studied 65 Treatment Naive HIV 65 Prostate Biopsy 65 Valve Replacement 65 Blood Thinner 65 Disease Severity 65 Subtypes 65 Reduces Risk 65 Advanced Renal Cell 65 Bypass Surgery 65 Asthma Symptoms 65 Generalized Anxiety Disorder 65 Confirmatory Phase 65 Testosterone Patch 65 Soft Tissue Sarcoma 65 Spectrum Pharmaceuticals Announces 65 Treatment Regimens 65 Myocardial Ischemia 65 Dose Ranging Study 65 Recurrent Breast Cancer 65 Prolonged Survival 65 Inhaled Nitric Oxide 65 Coronary Syndromes 65 Study Shows Benefits 65 Bone Fractures 65 Brentuximab Vedotin SGN 65 Coronary Artery Calcium 65 Files IND 65 Randomized Controlled 65 Immunosuppression 65 Cancer Treatments 65 Dose Response 65 Spinal Fusion 65 Kidney Failure 65 Allogeneic 65 Drug Coated Stent 65 Useful Tool 65 Rotavirus Vaccine 65 J Am Coll 65 Medoxomil 64 Randomized Phase II 64 Combination Clinical Trial 64 Abdominal Fat 64 Ischemic 64 Novel Mechanism 64 Knee Replacement Surgery 64 Complication Rates 64 Osteoarthritis Patients 64 Combination Therapy 64 Glatiramer Acetate 64 Prospective Randomized Trial 64 Tezampanel 64 Levels Linked 64 Mg Usa 64 Tyrosine Kinase Inhibitor 64 Prolongs Life 64 Rectal Cancer 64 Pain Relievers 64 Abciximab 64 Studies Suggest 64 J Allergy Clin 64 Myocardial Infarction 64 Male Infertility 64 Milestone Payment 64 Teva Provides Update 64 Genetic Tests 64 Pegylated Liposomal Doxorubicin 64 First Patient Treated 64 Initiates Phase III 64 Colorectal Cancer Risk 64 Blood Pressure Drugs 64 Hypercholesterolemia 64 Antiplatelet Therapy 64 Coronary Artery Bypass Surgery 64 Patient Treated 64 Secondary Endpoints 64 Virus Infection 64 Study Proves 64 Improves Quality 64 Prospective Randomized Study 64 Chronic Renal Failure 64 Demonstrate Significant 64 Contrast Enhanced 64 Corneal Transplant 64 Hip Fracture 64 Glucose Control 64 Diabetic Neuropathy 64 Randomised Controlled Trial 64 Total Knee Replacement 64 Molecular Mechanism 64 Neovascular Age Related Macular 64 Septic Shock 64 Newly Diagnosed Patients 64 Embolic Protection 64 Lymph Nodes 64 Subarachnoid Hemorrhage 64 AMCG DEST FISH HUDV 64 Telaprevir VX 64 See WARNINGS 64 Transplant Patients 64 Drug Fails 64 Eye Infections 64 Epilepsy Drugs 64 Thrombolytic Therapy 64 Lowering Blood Pressure 64 Hemoglobin Levels 64 Announces FDA Clearance 64 Acute Heart Failure 64 Radiation Dose 64 Inflammatory Response 64 Guidelines Issued 64 Commonly Used 64 Urinary Incontinence 64 Study Sheds Light 64 Intravitreal 64 Treating Heart Failure 64 Low Density Lipoprotein Cholesterol 64 Multicenter Randomized Double 64 #-# Full Text 64 Metastatic Pancreatic Cancer 64 Cypher Sirolimus 64 ST Elevation Acute 64 Immune Responses 64 Lymph Node 64 Nat Clin Pract 64 Eye Diseases 64 Psychiatric Disorders 64 Heart Attacks 64 Successfully Treated 64 Fecal Incontinence 64 Univest Corporation Declares 64 Novel Antibiotic 64 Treatment Shows Promise 64 Migraine Sufferers 64 Cancer Recurrence 64 Lung Injury 64 Hospitalized Patients 64 Renal Anemia 64 Arterial Disease 64 Statin Use 64 Coronary Artery Bypass Graft 64 Expanded Indication 64 Antidepressants Linked 64 Shows Promise Against 64 Test Detects 64 RENAL 64 Heartburn Drugs 64 Cardiotoxicity 64 Gender Differences 64 Aggressive Reduction 64 Viral Infection 64 Calcium Intake 64 Carotid Artery 64 Oral Presentations 64 Predictive Value 64 Inhaled Steroids 64 Sustained Reduction 64 Asthma Attacks 64 Cardiac Resynchronization 64 Functional Outcomes 64 Stress Incontinence 64 Stomach Cancer 64 Clinically Proven 64 Diabetic Kidney Disease 64 Guidelines Recommend 64 Deep Venous Thrombosis 64 Glucose Levels 64 Present Preclinical Data 64 Intracerebral 64 Coronary Intervention 64 Arch Neurol 64 Bone Marrow Transplants 64 Cardiol 64 Postmenopausal Osteoporosis 64 Schizophrenia Drug 64 Asthma Medication 64 Preclinical Models 64 Lung Function 64 Randomized Phase III 64 Stem Cell Transplants 64 Peginterferon Alfa 2b 64 Testosterone Gel 64 Interferon Beta 64 Prognostic Factors 64 Cocaine Addiction 64 Significant Improvements 64 Orthop Surg 64 Preterm Delivery 64 Novel Compounds 64 Moderate Drinking 64 Ovary Removal 64 J Pediatr 64 Endocrine Therapy 64 Unstable Angina Non 64 Autoimmune Disease 64 Initiate Phase 64 Blood Thinners 64 Aneurysm Repair 64 BIOLASE Announces 64 Breast Tumors 64 Meet Primary Endpoint 64 Device Helps 63 Genes Identified 63 Dose Finding 63 Male Contraceptive 63 Shingles Vaccine 63 Acute Pancreatitis 63 Collaborators Present 63 Skeletal Muscle 63 Laryngeal Cancer 63 Prostate Cancers 63 Organ Rejection 63 Antibiotic Use 63 Study Casts Doubt 63 Bare Metal Stent 63 REPORTS THIRD QUARTER 63 Novel Compound 63 Postherpetic Neuralgia 63 Phase III Clinical Trials 63 Heart Failure Therapy 63 Refractory Hodgkin Lymphoma 63 Adefovir 63 Million Cribs Recalled 63 Malignancies 63 Gastrointestinal Disorders 63 Cholesterol Lowering 63 Shows Statistically Significant 63 Significant Reduction 63 Uterine Fibroids 63 Relapsed 63 CLINICAL TRIAL 63 PPD Declares 63 Total Hip Arthroplasty 63 VITAL SIGNS 63 Insulin Therapy 63 Premature Babies 63 Taro Receives 63 Phase 1b Clinical Trial 63 Efficacy Results 63 Oral Contraceptives 63 Implantable Defibrillator 63 Receives FDA Clearance 63 Intravenous Formulation 63 COPD Exacerbations 63 Induction Therapy 63 Hernia Repair 63 Inherited Diseases 63 Paclitaxel Carboplatin 63 Genetic Defect 63 Antidepressant Treatment 63 Hepatitis C Virus Infection 63 Decompensated Heart Failure 63 Nymox NX 63 Initiates Phase 63 Percutaneous Coronary Intervention 63 Breast Ultrasound 63 Prostate Cancer Vaccine 63 NMDA Receptor 63 Hosp Epidemiol 63 Stent Coating 63 Helps Identify 63 Left Ventricular Dysfunction 63 Bone Marrow Cells 63 Pneumococcal Vaccine 63 Successfully Completes Phase 63 Breast Cancer Stem Cells 63 Balloon Angioplasty 63 Study Confirms 63 Bosutinib 63 Breast Tissue 63 Progenitor Cells 63 Crit Rev 63 Renal Cancer 63 Lower Blood Pressure 63 Lung Cancer Drug 63 Mortality Risk 63 Predict Prostate Cancer 63 FEMALES SHOULD BE ADVISED 63 Breast Cancer Cells 63 Juvenile Idiopathic Arthritis 63 Coronary Angiography 63 Initiate Clinical Trial 63 Lung Cancer Surgery 63 Oral Contraceptive 63 Adjunctive Treatment 63 Technological Advances 63 Breast Carcinoma 63 Primary Endpoint 63 Liver Injury 63 Thyroid Hormone 63 Who Underwent 63 Neurosurg 63 Spinal Fractures 63 Magnetic Stimulation 63 COVIDIEN 63 WE WILL CONTINUE TO 63 Patent Covering 63 Major Averages Close 63 Gene Therapy Trial 63 Muscle Wasting 63 Tablet Formulation 63 Antipsychotic Medications 63 Novel Inhibitor 63 Presents Preclinical Data 63 Hepatic Encephalopathy 63 Free Full Text 63 Detecting Breast Cancer 63 Skin Grafts 63 Am J Clin 63 Proc Am Soc 63 Efficacious 63 Prostate Cancer Diagnosis 63 Lupus Nephritis 63 Protease Inhibitor 63 Inflammatory Disease 63 Randomized Double blind 63 Naive Patients 63 Blood Clot Risk 63 Invasive Fungal Infections 63 Adjuvant Breast Cancer 63 Viral Load 63 Hospital Acquired Pneumonia 63 Kidney Transplantation 63 Anthracycline 63 Chronic HCV 63 Replacement Therapy 63 Pivotal Trials 63 Morbidity Mortality 63 的 中 63 FDA Panel Recommends 63 Help Predict 63 Therapy Reduces 63 Aortic Dissection 63 TECHNOLOGIST 63 Atypical Hemolytic Uremic Syndrome 63 Non Alcoholic Steatohepatitis 63 Granted Orphan Drug 63 Platelet Aggregation 63 Signaling Pathway 63 Mitral Valve Repair 63 Fondaparinux 63 Prospective Multicenter 63 Initiate Phase III 63 Initiated Phase 63 Gene Mutation Linked 63 Genes Involved 63 Novel Treatments 63 Gastrointestinal Stromal Tumors 63 Announcement acc 63 Knee Implant 63 Chemotherapy Induced 63 atazanavir sulfate 63 Radiation Induced 63 Tumor Cells 63 Hospitalization Rates 63 Adverse Effects 63 Pegylated Interferon 63 Prostate Tumors 63 CABG Surgery 63 Heart Circ Physiol 63 Prostate Screening 63 Virtual Colonoscopy 63 Differential Diagnosis 63 Shows Promise 63 Generic Version 62 Coronary Arteries 62 Remains Flat 62 Polymerase Inhibitor 62 Brain Cells 62 Dementia Patients 62 Abnormality 62 Carotid 62 PEDIATRICS 62 Pharmacologic Treatment 62 Rheumatoid Arthritis Drug 62 Inhibits 62 Insulin Resistance 62 Endometrial Ablation 62 Heart Transplants 62 HYPERTENSION 62 Hepatitis B Vaccine 62 Patient Enrolment 62 J Foot Ankle 62 Initiates Phase II 62 Multicenter 62 Diabetic Foot Ulcers 62 Placebo Effect 62 Watchful Waiting 62 Squamous Cell Carcinoma 62 Colon Polyps 62 Insulin Sensitivity 62 Electrical Stimulation 62 Correlation Between 62 Transdermal Patch 62 Cholesterol Lowering Drugs 62 Multicenter Double 62 Lung Cancer Diagnosis 62 Carotid Artery Stenting 62 Commonly Prescribed 62 Dendritic Cells 62 Genetic Variant 62 Acne Scars 62 BY CHARLIE MORASCH ARKANSAS 62 Impairs 62 Preterm Labor 62 Arimidex Tamoxifen Alone 62 Cardiovascular Risk Reduction 62 Prenatal Diagnosis 62 Vertebral Fracture 62 Weight Loss Drug 62 Ear Infections 62 Female Stress Urinary 62 Diagnostic Criteria 62 Protein Linked 62 Non Alcoholic Fatty 62 Int J Obes Relat 62 Inflammatory Diseases 62 Breast Exams 62 Cause Mortality 62 Disease Modifying 62 Herbal Extract 62 Valsartan 62 Portal Hypertension 62 DETECTS POSSIBLE BULLISH HARAMI 62 Proves Successful 62 Drug Eluting Coronary Stent 62 Valopicitabine NM# 62 Anti CD# Antibody 62 dual endothelin receptor antagonist 62 Dose Reduction 62 Treatment Naïve Patients 62 Clot Risk 62 Metabolic Efficiency 62 Peripheral Arterial 62 Pharmaceuticals Initiates 62 Neurol 62 Diabetic Foot Ulcer 62 TUMORS 62 Shoulder Prosthesis 62 Immune Cells 62 Genetic Markers 62 Prevent Fractures 62 Liver Transplants 62 Prostatic 62 Angiographic